Research map: ABO-incompatibility and hepatocellular carcinoma recurrence after living donor liver transplantation: stratified by tumor burden

Back to the article

Papers in this map

  1. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis · Vincenzo Mazzaferro · 1996 · 7224 citations · Cited by this paper
  2. Prepared or at-risk? Evaluating live viral vaccine coverage and vaccine immunogenicity before pediatric solid organ transplantation · 2026 · Related
  3. Hepatocellular carcinoma · Josep Maria Llovet · 2021 · 6739 citations · Cited by this paper
  4. Undersized lung grafts in chronic obstructive pulmonary disease transplant recipients: risk factor or acceptable compromise? · 2026 · Related
  5. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis · Vincenzo Mazzaferro · 2008 · 2060 citations · Cited by this paper
  6. Cold ischemia time exceeding 12 hours is a risk factor for delayed graft function and increased mortality in kidney transplant recipients within the eurotransplant senior program · 2026 · Related
  7. Cyclosporine induces cancer progression by a cell-autonomous mechanism · Minoru Hojo · 1999 · 1162 citations · Cited by this paper
  8. 4th workshop purification therapies, from research to clinics “the end of the beginning”: executive summary · 2026 · Related
  9. Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria · Christophe Duvoux · 2012 · 967 citations · Cited by this paper
  10. “A shared enemy to confront“: the experience and needs of the partners of kidney transplant patients - a qualitative study · 2026 · Related
  11. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma · Edward Kenneth Geissler · 2015 · 432 citations · Cited by this paper
  12. Serum α-Klotho and SIRT1 - Relationship with graft function, inflammation and hospitalization rates in kidney transplant recipients · 2026 · Related
  13. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant · Neil J. Mehta · 2016 · 403 citations · Cited by this paper
  14. Joint exposure to plasma heavy metals and the risk of kidney graft failure · 2026 · Related
  15. Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression · Mary Alice Maluccio · 2003 · 278 citations · Cited by this paper
  16. Seeking global agreement on controlled donation after circulatory determination of death: methodology and definitions of the Bucharest international European Society for Organ Transplantation (ESOT) consensus · 2026 · Related
  17. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma · Manuel Rodríguez‐Perálvarez · 2013 · 264 citations · Cited by this paper
  18. The Critical Role of Mental Health Specialists in Organ Transplantation Teams: An ELPAT Position Statement · 2026 · Related
  19. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression · Marco Vivarelli · 2005 · 219 citations · Cited by this paper
  20. Burden of infectious diseases in children during the first year after solid organ transplantation · 2026 · Related
  21. Present status of ABO-incompatible living donor liver transplantation in Japan · Hiroto Egawa · 2007 · 205 citations · Cited by this paper
  22. Liver transplantation for hepatocellular carcinoma: Management after the transplant · Elizabeth C. Verna · 2019 · 150 citations · Cited by this paper
  23. ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab · G.-W. Song · 2015 · 140 citations · Cited by this paper
  24. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry · Jong Man Kim · 2021 · 77 citations · Cited by this paper
  25. Current Status of ABO-incompatible Liver Transplantation · Hiroto Egawa · 2022 · 61 citations · Cited by this paper
  26. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma · Young‐In Yoon · 2018 · 51 citations · Cited by this paper
  27. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma · Shin Hwang · 2016 · 46 citations · Cited by this paper
  28. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation · Jongwook Oh · 2019 · 41 citations · Cited by this paper
  29. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence · Jong Man Kim · 2018 · 31 citations · Cited by this paper
  30. Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation · Shin Hwang · 2021 · 26 citations · Cited by this paper
  31. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation · Seong Hoon Kim · 2018 · 20 citations · Cited by this paper
  32. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab · Seung Duk Lee · 2014 · 19 citations · Cited by this paper
  33. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database · Gil‐Chun Park · 2020 · 13 citations · Cited by this paper
  34. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea–Japan collaborative study with 9200 patients · Woo‐Hyoung Kang · 2023 · 8 citations · Cited by this paper
  35. Long-Term Prognostic Value of AFP and PIVKA-II in HCC After Living Donor Liver Transplantation: A Single-Center Retrospective Study · Saran Ochir Gongor · 2025 · 6 citations · Cited by this paper
  36. Number of Pretransplant Therapeutic Plasma Exchange Sessions Increase the Recurrence Risk of Hepatocellular Carcinoma in ABO-Incompatible Living Donor Liver Transplantation · Young Jin Yoo · 2025 · 4 citations · Cited by this paper
  37. Association between the early high level of serum tacrolimus and recurrence of hepatocellular carcinoma in ABO-incompatible liver transplantation · Ji Won Han · 2023 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)